Pervasis Drug Candidate Receives EU Orphan Drug Status

Pervasis Therapeutics Inc. has won orphan drug designation from the European Commission for its lead drug Vascugel, a prevention treatment of kidney dialysis access failure in patients with end stage renal disease.
Mass High Tech